Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Debruyne

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Behavioral Medicine|November 22, 2015
Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?Stefaan Van Damme, Annelies De Waegeneer, Jan Debruyne
Neuropsychologia|March 29, 2008
Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosisNele P Warlop, Eric Achten, Jan Debruyne, et al.
Brain Research|June 28, 2008
Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imagingNele P Warlop, Els Fieremans, Eric Achten, et al.
Brain and Cognition|July 7, 2009
Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosisNele P Warlop, Eric Achten, Els Fieremans, et al.
Psychology & Health|January 29, 2019
The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosisStefaan Van Damme, Sara Kindt, Geert Crombez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 5, 2012
White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisMelissa Cambron, Miguel D'Haeseleer, Guy Laureys, et al.
Journal of Neurology|September 7, 2018
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, <sup>1</sup>H and <sup>31</sup>P MRS, and clinical and cognitive testingMelissa Cambron, Tatjana Reynders, Jan Debruyne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2019
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trialMelissa Cambron, Jop Mostert, Marie D'Hooghe, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Clinical Neurology and Neurosurgery|July 25, 2013
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDirk De Ridder, Frank Van Der Aa, Jan Debruyne, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Behavioral Medicine|November 22, 2015
Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?Stefaan Van Damme, Annelies De Waegeneer, Jan Debruyne
Neuropsychologia|March 29, 2008
Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosisNele P Warlop, Eric Achten, Jan Debruyne, et al.
Brain Research|June 28, 2008
Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imagingNele P Warlop, Els Fieremans, Eric Achten, et al.
Brain and Cognition|July 7, 2009
Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosisNele P Warlop, Eric Achten, Els Fieremans, et al.
Psychology & Health|January 29, 2019
The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosisStefaan Van Damme, Sara Kindt, Geert Crombez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 5, 2012
White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisMelissa Cambron, Miguel D'Haeseleer, Guy Laureys, et al.
Journal of Neurology|September 7, 2018
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, <sup>1</sup>H and <sup>31</sup>P MRS, and clinical and cognitive testingMelissa Cambron, Tatjana Reynders, Jan Debruyne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2019
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trialMelissa Cambron, Jop Mostert, Marie D'Hooghe, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Clinical Neurology and Neurosurgery|July 25, 2013
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDirk De Ridder, Frank Van Der Aa, Jan Debruyne, et al.
Pageof 2